FDA Orange Book
Is there a generic for Nevanac?
Nevanac contains nepafenac. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Nevanac (nepafenac). The Orange Book shows its last listed patent expires January 31, 2027.
Run it in Rivvi
Map Nevanac and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Nevanac products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| suspension/drops, ophthalmic | 0.1% | Marketed (Rx) | None | 0 | None |
NDA 021862, held by HARROW EYE LLC. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Nevanac patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 7834059 | January 31, 2027 | Method of use | U-1095 | 021862 |
Nevanac NDC codes
Questions
Is there a generic for Nevanac?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Nevanac (nepafenac). The Orange Book shows its last listed patent expires January 31, 2027.
What is the generic name for Nevanac?
The active ingredient in Nevanac is nepafenac, per the FDA Orange Book.
When does the Nevanac patent expire?
The last patent listed for Nevanac in the Orange Book expires January 31, 2027. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.